Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2012

01-12-2012 | Epidemiology

Time to diagnosis and breast cancer stage by race/ethnicity

Authors: Erica T. Warner, Rulla M. Tamimi, Melissa E. Hughes, Rebecca A. Ottesen, Yu-Ning Wong, Stephen B. Edge, Richard L. Theriault, Douglas W. Blayney, Joyce C. Niland, Eric P. Winer, Jane C. Weeks, Ann H. Partridge

Published in: Breast Cancer Research and Treatment | Issue 3/2012

Login to get access

Abstract

We examined differences in time to diagnosis by race/ethnicity, the relationship between time to diagnosis and stage, and the extent to which it explains differences in stage at diagnosis across racial/ethnic groups. Our analytic sample includes 21,427 non-Hispanic White (White), Hispanic, non-Hispanic Black (Black) and non-Hispanic Asian/Pacific Islander (Asian) women diagnosed with stage I to IV breast cancer between January 1, 2000 and December 31, 2007 at one of eight National Comprehensive Cancer Network centers. We measured time from initial abnormal mammogram or symptom to breast cancer diagnosis. Stage was classified using AJCC criteria. Initial sign of breast cancer modified the association between race/ethnicity and time to diagnosis. Among symptomatic women, median time to diagnosis ranged from 36 days among Whites to 53.6 for Blacks. Among women with abnormal mammograms, median time to diagnosis ranged from 21 days among Whites to 29 for Blacks. Blacks had the highest proportion (26 %) of Stage III or IV tumors. After accounting for time to diagnosis, the observed increased risk of stage III/IV breast cancer was reduced from 40 to 28 % among Hispanics and from 113 to 100 % among Blacks, but estimates remained statistically significant. We were unable to fully account for the higher proportion of late-stage tumors among Blacks. Blacks and Hispanics experienced longer time to diagnosis than Whites, and Blacks were more likely to be diagnosed with late-stage tumors. Longer time to diagnosis did not fully explain differences in stage between racial/ethnicity groups.
Literature
1.
go back to reference National Cancer Institute, Surveillance Research Program (2011) Fast Stats: An interactive tool for access to SEER cancer statistics National Cancer Institute, Surveillance Research Program (2011) Fast Stats: An interactive tool for access to SEER cancer statistics
2.
3.
go back to reference Arndt V, Stürmer T, Stegmaier C et al (2003) Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 21:1440PubMedCrossRef Arndt V, Stürmer T, Stegmaier C et al (2003) Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 21:1440PubMedCrossRef
4.
go back to reference Gorin SS, Heck JE, Cheng B et al (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252PubMedCrossRef Gorin SS, Heck JE, Cheng B et al (2006) Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 166:2244–2252PubMedCrossRef
5.
go back to reference Caplan LS, Helzlsouer KJ (1992) Delay in breast cancer: a review of the literature. Public Health Rev 20:187–214PubMed Caplan LS, Helzlsouer KJ (1992) Delay in breast cancer: a review of the literature. Public Health Rev 20:187–214PubMed
6.
go back to reference Caplan LS, Helzlsouer KJ, Shapiro S et al (1995) System delay in breast cancer in whites and blacks. Am J Epidemiol 142:804PubMed Caplan LS, Helzlsouer KJ, Shapiro S et al (1995) System delay in breast cancer in whites and blacks. Am J Epidemiol 142:804PubMed
7.
go back to reference Wujcik D, Fair AM (2008) Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Cancer Nurs 31:E16–E30PubMedCrossRef Wujcik D, Fair AM (2008) Barriers to diagnostic resolution after abnormal mammography: a review of the literature. Cancer Nurs 31:E16–E30PubMedCrossRef
8.
go back to reference Wujcik D, Shyr Y, Li M et al (2009) Delay in diagnostic testing after abnormal mammography in low-income women. Oncol Nurs Forum 36:709–715PubMedCrossRef Wujcik D, Shyr Y, Li M et al (2009) Delay in diagnostic testing after abnormal mammography in low-income women. Oncol Nurs Forum 36:709–715PubMedCrossRef
9.
go back to reference Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595–1604PubMedCrossRef Gwyn K, Bondy ML, Cohen DS et al (2004) Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100:1595–1604PubMedCrossRef
10.
go back to reference Richardson J, Langholz B, Bernstein L et al (1992) Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 65:922PubMedCrossRef Richardson J, Langholz B, Bernstein L et al (1992) Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer 65:922PubMedCrossRef
11.
go back to reference Richards MA, Smith P, Ramirez AJ et al (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858PubMedCrossRef Richards MA, Smith P, Ramirez AJ et al (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79:858PubMedCrossRef
12.
go back to reference Richards MA, Westcombe AM, Love SB et al (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353:1119–1126PubMedCrossRef Richards MA, Westcombe AM, Love SB et al (1999) Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353:1119–1126PubMedCrossRef
13.
go back to reference Greene FL (2002) AJCC cancer staging manual. Springer Verlag, Berlin Greene FL (2002) AJCC cancer staging manual. Springer Verlag, Berlin
14.
go back to reference Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef Singletary SE, Allred C, Ashley P et al (2002) Revision of the American Joint Committee on cancer staging system for breast cancer. J Clin Oncol 20:3628–3636PubMedCrossRef
15.
go back to reference Weeks J (1999) Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network. Oncology (Williston Park) 13:69–71 Weeks J (1999) Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network. Oncology (Williston Park) 13:69–71
16.
go back to reference Weeks JC (1997) Outcomes assessment in the NCCN. Oncology (Williston Park) 11:137–140 Weeks JC (1997) Outcomes assessment in the NCCN. Oncology (Williston Park) 11:137–140
17.
go back to reference Niland JC (2000) NCCN outcomes research database: data collection via the Internet. Oncology (Williston Park) 14:100–103 Niland JC (2000) NCCN outcomes research database: data collection via the Internet. Oncology (Williston Park) 14:100–103
18.
go back to reference Christian CK, Niland J, Edge SB et al (2006) A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg 243:241PubMedCrossRef Christian CK, Niland J, Edge SB et al (2006) A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg 243:241PubMedCrossRef
19.
go back to reference Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165–172CrossRef Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165–172CrossRef
20.
go back to reference Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84PubMedCrossRef Katz JN, Chang LC, Sangha O et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73–84PubMedCrossRef
21.
go back to reference Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383PubMedCrossRef
22.
go back to reference Adams SA, Smith ER, Hardin J et al (2009) Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women. Cancer 115:5788–5797PubMedCrossRef Adams SA, Smith ER, Hardin J et al (2009) Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women. Cancer 115:5788–5797PubMedCrossRef
23.
go back to reference Kerner JF, Yedidia M, Padgett D et al (2003) Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women. Prev Med 37:92–101PubMedCrossRef Kerner JF, Yedidia M, Padgett D et al (2003) Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women. Prev Med 37:92–101PubMedCrossRef
24.
go back to reference Taplin SH, Ichikawa L, Yood MU et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96:1518PubMedCrossRef Taplin SH, Ichikawa L, Yood MU et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96:1518PubMedCrossRef
25.
go back to reference Bish A, Ramirez A, Burgess C et al (2005) Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res 58:321–326PubMedCrossRef Bish A, Ramirez A, Burgess C et al (2005) Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res 58:321–326PubMedCrossRef
26.
go back to reference Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366:825–831PubMedCrossRef Smith LK, Pope C, Botha JL (2005) Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet 366:825–831PubMedCrossRef
27.
go back to reference Burgess C, Ramirez A, Richards M et al (1998) Who and what influences delayed presentation in breast cancer? Br J Cancer 77:1343PubMedCrossRef Burgess C, Ramirez A, Richards M et al (1998) Who and what influences delayed presentation in breast cancer? Br J Cancer 77:1343PubMedCrossRef
28.
go back to reference Lobb R, Allen JD, Emmons KM et al (2010) Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med 170:521–528PubMedCrossRef Lobb R, Allen JD, Emmons KM et al (2010) Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med 170:521–528PubMedCrossRef
29.
go back to reference Gabram SGA, Lund MJB, Gardner J et al (2008) Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer 113:602–607PubMedCrossRef Gabram SGA, Lund MJB, Gardner J et al (2008) Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population. Cancer 113:602–607PubMedCrossRef
30.
go back to reference Ell K, Vourlekis B, Lee PJ et al (2007) Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med 44:26–33PubMedCrossRef Ell K, Vourlekis B, Lee PJ et al (2007) Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev Med 44:26–33PubMedCrossRef
31.
go back to reference Ferrante JM, Chen PH, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85:114–124PubMedCrossRef Ferrante JM, Chen PH, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J Urban Health 85:114–124PubMedCrossRef
32.
go back to reference Baquet CR, Mishra SI, Commiskey P et al (2008) Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 100:480PubMed Baquet CR, Mishra SI, Commiskey P et al (2008) Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 100:480PubMed
33.
go back to reference Lantz PM, Mujahid M, Schwartz K et al (2006) The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health 96:2173PubMedCrossRef Lantz PM, Mujahid M, Schwartz K et al (2006) The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health 96:2173PubMedCrossRef
34.
go back to reference Mandelblatt J, Andrews H, Kao R et al (2010) Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 6:342–351CrossRef Mandelblatt J, Andrews H, Kao R et al (2010) Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 6:342–351CrossRef
35.
go back to reference Ademuyiwa FO, Edge SB, Erwin DO et al (2011) Breast cancer racial disparities: unanswered questions. Cancer Res 71:640–644PubMedCrossRef Ademuyiwa FO, Edge SB, Erwin DO et al (2011) Breast cancer racial disparities: unanswered questions. Cancer Res 71:640–644PubMedCrossRef
36.
go back to reference Ademuyiwa FO, Olopade OI (2003) Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 22:47–53PubMedCrossRef Ademuyiwa FO, Olopade OI (2003) Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 22:47–53PubMedCrossRef
37.
go back to reference Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRef
38.
go back to reference Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65PubMedCrossRef Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65PubMedCrossRef
39.
go back to reference Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMedCrossRef Chlebowski RT, Chen Z, Anderson GL et al (2005) Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97:439–448PubMedCrossRef
40.
go back to reference Warnecke RB, Oh A, Breen N et al (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98:1608–1615PubMedCrossRef Warnecke RB, Oh A, Breen N et al (2008) Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98:1608–1615PubMedCrossRef
Metadata
Title
Time to diagnosis and breast cancer stage by race/ethnicity
Authors
Erica T. Warner
Rulla M. Tamimi
Melissa E. Hughes
Rebecca A. Ottesen
Yu-Ning Wong
Stephen B. Edge
Richard L. Theriault
Douglas W. Blayney
Joyce C. Niland
Eric P. Winer
Jane C. Weeks
Ann H. Partridge
Publication date
01-12-2012
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2012
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-012-2304-1

Other articles of this Issue 3/2012

Breast Cancer Research and Treatment 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine